Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
100 participants
OBSERVATIONAL
2013-04-30
2015-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
1. After patients receive pharmaceutical care, their drug related problems will be decreased.
2. After patients received pharmaceutical care, their self-reported medical expenditure will be decreased.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Medication Management at Home Via Pharmacy Home Televisits
NCT04340570
Randomized Controlled Trial of Enhanced Pharmacy Care in Older Veteran Outpatients
NCT00122122
Pharmaceutical Care and Clinical Outcomes for the Elderly Taking Potentially Inappropriate Medication
NCT00844025
Medication Safety of Elderly Patients in Hospital and Ambulatory Setting
NCT01578525
Medication Reconciliation in Comparison to an Extensive Medication Safety Check
NCT02413957
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The inclusion criteria:
1. Residents of the Veteran nursing home.
2. over 65 years old.
3. complete comprehensive geriatric assessment (CGA)
4. prescription drugs more than 4 times/day, excluding stat order.
5. with 2 or more chronic diseases.
Exclusion criteria:
1\. residents who were in the pharmaceutical care project of Taiwan Pharmacists Association.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Non-pharmaceutical care
Veterans do not receiving pharmaceutical care
No interventions assigned to this group
Pharmaceutical care
Veterans receiving pharmaceutical care
Pharmaceutical care
pharmacists provide pharmaceutical care to the intervention group, comparing to ordinary care in control group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Pharmaceutical care
pharmacists provide pharmaceutical care to the intervention group, comparing to ordinary care in control group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age over 65 years old
* Complete Comprehensive Geriatric Assessment (CGA)
* Use more than 4 drug item per day (excluding stat order)
* subjects with more than 2 chronic diseases.
Exclusion Criteria
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Taichung Veterans General Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Wen-Shyong Liou, PhD
Role: PRINCIPAL_INVESTIGATOR
Taichung Veteran General Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Changhua Domiciliar Center
Changhua, Taiwan, Taiwan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TCVGHPHARM_RESEARCH_1
Identifier Type: OTHER
Identifier Source: secondary_id
VGHTCPHARMACY1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.